HealthPartners Research Foundation, Minneapolis, MN 55440-1524, USA.
Health Informatics J. 2009 Dec;15(4):296-304. doi: 10.1177/1460458209345900.
The purpose of this study was to assess whether an electronic prompt promoting BMD testing affected the proportion of patients who received BMD and/or bone health medication. Rheumatology providers of patients 40+, on prednisone, with no record of BMD testing in the past 2 years, were targeted with the message: 'This patient is at risk for osteoporosis due to prednisone use. We have no record of a recent Dexa scan.' We also surveyed providers on the prompt's value. The use of prednisone remained stable; BMD testing was quite low in all periods but increased slightly (non-statistically) over time, as did bone health medication use. Providers found the prompt not tailored enough to be clinically meaningful. Electronic prompts seem beneficial in theory; however, putting them into practice has challenges. While the EMR has great potential to improve care, more needs to be done to ensure optimal use.
这项研究的目的是评估电子提示是否会影响接受 BMD 检测和/或骨骼健康药物治疗的患者比例。针对过去 2 年内没有 BMD 检测记录、年龄在 40 岁以上、正在服用泼尼松的患者，向他们的风湿病医生发送信息：“由于使用泼尼松，该患者有骨质疏松的风险。我们没有最近的 Dexa 扫描记录。”我们还调查了医生对该提示的看法。泼尼松的使用保持稳定；所有时期的 BMD 检测都非常低，但随着时间的推移略有增加（无统计学意义），骨骼健康药物的使用也有所增加。医生认为该提示不够个性化，缺乏临床意义。电子提示在理论上似乎是有益的；然而，将其付诸实践存在挑战。尽管 EMR 具有改善医疗的巨大潜力，但还需要做更多的工作来确保其得到最佳利用。
